RTX Dual-Cycle Story in Play, But Filings Warn of Extended GTF Drag

What happened

A bullish Seeking Alpha article rates RTX a buy with a $201.85 target, citing surging defense spending and robust commercial aerospace demand underpinned by a $271B backlog, plus strong Q1 2026 results. However, the DeepValue report maintains a WAIT rating, noting that the stock at $180 already prices in a clean defense ramp while underweighting the filing reality that Pratt & Whitney's GTF aircraft-on-ground levels will remain elevated through 2026. Q1 momentum is real—organic sales up 10%, adjusted EPS up 21%—but Raytheon's defense backlog actually slipped sequentially, indicating delivery conversion lags bookings. The valuation, at 33.5x P/E and 21x EV/EBITDA, leaves little room for error if free cash flow guidance of $8.25–$8.75B falters or the GTF disruption extends. Until observable proof of supply chain throughput and GTF repair cycle gains emerges, the risk/reward remains skewed to the downside.

Implication

RTX's dual-cycle story is compelling long-term, but near-term risk/reward is unfavorable at ~33x earnings. The bullish article overlooks that Pratt's AOG is expected to stay high through 2026 and defense backlog isn't growing. Investors should look for entry near $160 (DeepValue attractive entry) or wait for two quarters of evidence that (1) Raytheon's missile deliveries are accelerating and (2) Pratt's MRO throughput is reducing cash drag. If these materialize, upsides to $200+ are real; if not, a reset to $150 is possible.

Thesis delta

The bullish narrative is gaining traction, but the core thesis remains: RTX is an execution story, not a demand story. The DeepValue report's skepticism around GTF duration and backlog conversion is not undermined by the article's optimistic tone. The risk is that the market may be pricing in a smooth GTF recovery that filings show is not yet assured.